179 related articles for article (PubMed ID: 33095126)
1. Protease-Resistant Growth Factor Formulations for the Healing of Chronic Wounds.
Boeringer T; Gould LJ; Koria P
Adv Wound Care (New Rochelle); 2020 Nov; 9(11):612-622. PubMed ID: 33095126
[No Abstract] [Full Text] [Related]
2. The development and characterization of SDF1α-elastin-like-peptide nanoparticles for wound healing.
Yeboah A; Cohen RI; Faulknor R; Schloss R; Yarmush ML; Berthiaume F
J Control Release; 2016 Jun; 232():238-47. PubMed ID: 27094603
[TBL] [Abstract][Full Text] [Related]
3. Defining a new diagnostic assessment parameter for wound care: Elevated protease activity, an indicator of nonhealing, for targeted protease-modulating treatment.
Serena TE; Cullen BM; Bayliff SW; Gibson MC; Carter MJ; Chen L; Yaakov RA; Samies J; Sabo M; DeMarco D; Le N; Galbraith J
Wound Repair Regen; 2016 May; 24(3):589-95. PubMed ID: 27027492
[TBL] [Abstract][Full Text] [Related]
4. Co-delivery of a growth factor and a tissue-protective molecule using elastin biopolymers accelerates wound healing in diabetic mice.
Devalliere J; Dooley K; Hu Y; Kelangi SS; Uygun BE; Yarmush ML
Biomaterials; 2017 Oct; 141():149-160. PubMed ID: 28688286
[TBL] [Abstract][Full Text] [Related]
5. Self-assembled elastin-like polypeptide fusion protein coacervates as competitive inhibitors of advanced glycation end-products enhance diabetic wound healing.
Kang HJ; Kumar S; D'Elia A; Dash B; Nanda V; Hsia HC; Yarmush ML; Berthiaume F
J Control Release; 2021 May; 333():176-187. PubMed ID: 33781808
[TBL] [Abstract][Full Text] [Related]
6. Self-assembling elastin-like peptides growth factor chimeric nanoparticles for the treatment of chronic wounds.
Koria P; Yagi H; Kitagawa Y; Megeed Z; Nahmias Y; Sheridan R; Yarmush ML
Proc Natl Acad Sci U S A; 2011 Jan; 108(3):1034-9. PubMed ID: 21193639
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional Elastin-Like Polypeptide Fusion Protein Coacervates Inhibit Receptor-Mediated Proinflammatory Signals and Promote Angiogenesis in Mouse Diabetic Wounds.
Kang HJ; Kumar S; Dash BC; Hsia HC; Yarmush ML; Berthiaume F
Adv Wound Care (New Rochelle); 2023 May; 12(5):241-255. PubMed ID: 34779253
[No Abstract] [Full Text] [Related]
8. Preparation and in vivo evaluation of cationic elastic liposomes comprising highly skin-permeable growth factors combined with hyaluronic acid for enhanced diabetic wound-healing therapy.
Choi JU; Lee SW; Pangeni R; Byun Y; Yoon IS; Park JW
Acta Biomater; 2017 Jul; 57():197-215. PubMed ID: 28476587
[TBL] [Abstract][Full Text] [Related]
9. Topical delivery of growth factors and metal/metal oxide nanoparticles to infected wounds by polymeric nanoparticles: an overview.
Alavi M; Rai M
Expert Rev Anti Infect Ther; 2020 Oct; 18(10):1021-1032. PubMed ID: 32536223
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing.
Lobmann R; Zemlin C; Motzkau M; Reschke K; Lehnert H
J Diabetes Complications; 2006; 20(5):329-35. PubMed ID: 16949521
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors.
Trengove NJ; Stacey MC; MacAuley S; Bennett N; Gibson J; Burslem F; Murphy G; Schultz G
Wound Repair Regen; 1999; 7(6):442-52. PubMed ID: 10633003
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial Use of Therapeutic ELP-Based Micelle Particles in Tissue Engineering.
Bulutoglu B; Acun A; Deng SL; Mert S; Lupon E; Lellouch AG; Cetrulo CL; Uygun BE; Yarmush ML
Adv Healthc Mater; 2022 Jul; 11(13):e2102795. PubMed ID: 35373501
[TBL] [Abstract][Full Text] [Related]
13. Influence of secretory leukocyte protease inhibitor-based peptides on elastase activity and their incorporation in hyaluronic acid hydrogels for chronic wound therapy.
Barros SC; Martins JA; Marcos JC; Cavaco-Paulo A
Biopolymers; 2012; 98(6):576-90. PubMed ID: 23203763
[TBL] [Abstract][Full Text] [Related]
14. Stem cells and growth factors-based delivery approaches for chronic wound repair and regeneration: A promise to heal from within.
Sharma P; Kumar A; Dey AD; Behl T; Chadha S
Life Sci; 2021 Mar; 268():118932. PubMed ID: 33400933
[TBL] [Abstract][Full Text] [Related]
15. Stromal Cell-Derived Growth Factor-1 Alpha-Elastin Like Peptide Fusion Protein Promotes Cell Migration and Revascularization of Experimental Wounds in Diabetic Mice.
Yeboah A; Maguire T; Schloss R; Berthiaume F; Yarmush ML
Adv Wound Care (New Rochelle); 2017 Jan; 6(1):10-22. PubMed ID: 28116224
[No Abstract] [Full Text] [Related]
16. In vitro inhibition of human neutrophil elastase by oleic acid albumin formulations from derivatized cotton wound dressings.
Edwards JV; Howley P; Cohen IK
Int J Pharm; 2004 Oct; 284(1-2):1-12. PubMed ID: 15454291
[TBL] [Abstract][Full Text] [Related]
17. A review of the literature on topical therapies for diabetic foot ulcers. Part 2: Advanced treatments.
White R; McIntosh C
J Wound Care; 2009 Aug; 18(8):335-41. PubMed ID: 19862873
[TBL] [Abstract][Full Text] [Related]
18. The wound healing effects of the Tilapia collagen peptide mixture TY001 in streptozotocin diabetic mice.
Xiong X; Liang J; Xu Y; Liu J; Liu Y
J Sci Food Agric; 2020 May; 100(7):2848-2858. PubMed ID: 31646634
[TBL] [Abstract][Full Text] [Related]
19. Approaches to Modulate the Chronic Wound Environment Using Localized Nucleic Acid Delivery.
Berger AG; Chou JJ; Hammond PT
Adv Wound Care (New Rochelle); 2021 Sep; 10(9):503-528. PubMed ID: 32496978
[No Abstract] [Full Text] [Related]
20. Enhanced regenerative healing efficacy of a highly skin-permeable growth factor nanocomplex in a full-thickness excisional mouse wound model.
Bae IH; Park JW; Kim DY
Int J Nanomedicine; 2014; 9():4551-67. PubMed ID: 25288883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
